Design, synthesis and biological evaluation of pyridone-aminal derivatives as MNK1/2 inhibitors
- PMID: 30824167
- DOI: 10.1016/j.bmc.2019.02.007
Design, synthesis and biological evaluation of pyridone-aminal derivatives as MNK1/2 inhibitors
Abstract
Excessive phosphorylation of eukaryotic translation initiation factor 4E (eIF4E) plays a major role in the dysregulation of mRNA translation and the activation of tumor cell signaling. eIF4E is exclusively phosphorylated by mitogen-activated protein kinase interacting kinases 1 and 2 (MNK1/2) on Ser209. So, MNK1/2 inhibitors could decrease the level of p-eIF4E and regulate tumor-associated signaling pathways. A series of pyridone-aminal derivatives were synthesized and evaluated as MNK1/2 inhibitors. Several compounds exhibited great inhibitory activity against MNK1/2 and selected compounds showed moderate to excellent anti-proliferative potency against hematologic cancer cell lines. In particular, compound 42i (MNK1 IC50 = 7.0 nM; MNK2 IC50 = 6.1 nM) proved to be the most potent compound against TMD-8 cell line with IC50 value of 0.91 μM. Furthermore, 42i could block the phosphorylation level of eIF4E in CT-26 cell line, and 42i inhibited the tumor growth of CT-26 allograft model significantly. These results indicated that compound 42i was a promising MNK1/2 inhibitor for the potent treatment of colon cancer.
Keywords: MNK1/2; Pyridone–aminal; eFT508; eIF4E.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Similar articles
-
Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition.J Med Chem. 2018 Apr 26;61(8):3516-3540. doi: 10.1021/acs.jmedchem.7b01795. Epub 2018 Mar 29. J Med Chem. 2018. PMID: 29526098
-
Design, synthesis and biological evaluation of 4-(indolin-1-yl)-6-substituted-pyrido[3,2-d]pyrimidine derivatives as Mnk1/2 inhibitors.Eur J Med Chem. 2024 Jun 5;272:116499. doi: 10.1016/j.ejmech.2024.116499. Epub 2024 May 14. Eur J Med Chem. 2024. PMID: 38759457
-
Design, synthesis and biological evaluation of 4-aniline-thieno[2,3-d]pyrimidine derivatives as MNK1 inhibitors against renal cell carcinoma and nasopharyngeal carcinoma.Bioorg Med Chem. 2019 Jun 1;27(11):2268-2279. doi: 10.1016/j.bmc.2019.04.022. Epub 2019 Apr 17. Bioorg Med Chem. 2019. PMID: 31014565
-
Mitogen-activated Protein Kinase (MAPK) Interacting Kinases 1 and 2 (MNK1 and MNK2) as Targets for Cancer Therapy: Recent Progress in the Development of MNK Inhibitors.Curr Med Chem. 2017;24(28):3025-3053. doi: 10.2174/0929867324666170203123427. Curr Med Chem. 2017. PMID: 28164761 Review.
-
Update on the Development of MNK Inhibitors as Therapeutic Agents.J Med Chem. 2022 Jan 27;65(2):983-1007. doi: 10.1021/acs.jmedchem.1c00368. Epub 2021 Sep 17. J Med Chem. 2022. PMID: 34533957 Review.
Cited by
-
Targeting Protein Synthesis in Colorectal Cancer.Cancers (Basel). 2020 May 21;12(5):1298. doi: 10.3390/cancers12051298. Cancers (Basel). 2020. PMID: 32455578 Free PMC article. Review.
-
Translation initiation and its relevance in colorectal cancer.FEBS J. 2021 Dec;288(23):6635-6651. doi: 10.1111/febs.15690. Epub 2021 Jan 24. FEBS J. 2021. PMID: 33382175 Free PMC article. Review.
-
Deeping in the Role of the MAP-Kinases Interacting Kinases (MNKs) in Cancer.Int J Mol Sci. 2020 Apr 23;21(8):2967. doi: 10.3390/ijms21082967. Int J Mol Sci. 2020. PMID: 32340135 Free PMC article. Review.
-
Mono- and Diamination of 4,6-Dichloropyrimidine, 2,6-Dichloropyrazine and 1,3-Dichloroisoquinoline with Adamantane-Containing Amines.Molecules. 2021 Mar 29;26(7):1910. doi: 10.3390/molecules26071910. Molecules. 2021. PMID: 33805408 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
